Treating Irritable Bowel Disease (Crohn’s disease, Ulcerative Colitis) with Hyperbaric Oxygen Therapy

HBOT is an incredible adjunct to conventional drugs because it reduces acute and chronic inflammation, enhances all stages of wound healing, mobilizes stem cells and stimulates growth factors essential to tissue repair and modulates the immune response all while enhancing plasma oxygen up to 1200% to target tissue hypoxia – a key factor in IBD.

Limited high-quality evidence suggests that HBOT is safe and associated with substantial rates of clinical remission for multiple IBD phenotypes. Well-designed randomized controlled trials are warranted to confirm the benefit of HBOT in IBD.

Researchers have shown that more than 80% of patients with Crohn’s disease did report some improvement in their symptoms. Almost 50% of patients who had a fistula experienced full recovery.

A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease https://pmc.ncbi.nlm.nih.gov/articles/PMC8554584/

The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis https://academic.oup.com/ibdjournal/article/28/4/611/6277724

The new insights of hyperbaric oxygen therapy: focus on inflammatory bowel disease https://academic.oup.com/pcm/article/7/1/pbae001/7577619

Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn’s disease https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05317-1